BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 20644462)

  • 1. Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration.
    Marschalkó M; Eros N; Holló P; Hársing J; Bottlik G; Bátai A; Csukly Z; Masszi T; Szentirmai Z; Fodor J; Kárpáti S; Matolcsy A; Csomor J
    Am J Dermatopathol; 2010 Oct; 32(7):708-12. PubMed ID: 20644462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of systemic anaplastic large cell lymphoma with 'Hodgkin-like' appearance and skin involvement mimicking lymphomatoid papulosis.
    Kiniwa Y; Ide Y; Fukushima M; Asano N; Saida T
    J Cutan Pathol; 2011 Jan; 38(1):38-42. PubMed ID: 20002236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules.
    Bird JE; Leitenberger JJ; Solomon A; Blauvelt A; Hopkins S
    Dermatol Online J; 2012 May; 18(5):5. PubMed ID: 22630575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects--a review.
    ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Meijer CJ
    J Pathol; 2003 May; 200(1):4-15. PubMed ID: 12692835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nodal anaplastic large-cell lymphoma ALK-1- with CD30+ cutaneous lymphoproliferation treated with mistletoe: spontaneous remission or treatment response?
    Kameda G; Kempf W; Oschlies I; Michael K; Seifert G; Längler A
    Klin Padiatr; 2011 Nov; 223(6):364-7. PubMed ID: 22052633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis.
    Beylot-Barry M; Lamant L; Vergier B; de Muret A; Fraitag S; Delord B; Dubus P; Vaillant L; Delaunay M; MacGrogan G; Beylot C; de Mascarel A; Delsol G; Merlio JP
    Am J Pathol; 1996 Aug; 149(2):483-92. PubMed ID: 8701987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of anaplastic lymphoma kinase (ALK) and Epstein-Barr virus gene products in primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis.
    Herbst H; Sander C; Tronnier M; Kutzner H; Hügel H; Kaudewitz P
    Br J Dermatol; 1997 Nov; 137(5):680-6. PubMed ID: 9415224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALK-positive anaplastic large cell lymphoma in a patient with chronic lymphocytic leukemia.
    Liu T; He M; Carlson DL; Hedvat C; Teruya-Feldstein J
    Int J Surg Pathol; 2010 Oct; 18(5):424-8. PubMed ID: 18794171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative.
    Kadin ME; Pinkus JL; Pinkus GS; Duran IH; Fuller CE; Onciu M; Kawaguchi H; Morris SW
    Am J Surg Pathol; 2008 Sep; 32(9):1421-6. PubMed ID: 18670345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
    Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
    Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal T-cell receptor β-chain gene rearrangements in differential diagnosis of lymphomatoid papulosis from skin metastasis of nodal anaplastic large-cell lymphoma.
    Akilov OE; Pillai RK; Grandinetti LM; Kant JA; Geskin L
    Arch Dermatol; 2011 Aug; 147(8):943-7. PubMed ID: 21844453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphohistiocytic anaplastic large cell lymphoma involving skin: a diagnostic challenge.
    Chuang SS; Hsieh YC; Ye H; Hwang WS
    Pathol Res Pract; 2009; 205(4):283-7. PubMed ID: 19091487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus in CD30 anaplastic large cell lymphoma involving the skin and lymphomatoid papulosis in South Korea.
    Kim YC; Yang WI; Lee MG; Kim SN; Cho KH; Lee SJ; Lee MW; Koh JK
    Int J Dermatol; 2006 Nov; 45(11):1312-6. PubMed ID: 17076712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaplastic large cell lymphoma: an unusual presentation in a 7-year-old girl.
    Ju E; Adigun C; Dunphy C; Gold S; Morrell DS
    Pediatr Dermatol; 2012; 29(4):498-503. PubMed ID: 21967522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
    Querfeld C; Khan I; Mahon B; Nelson BP; Rosen ST; Evens AM
    Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALK-negative anaplastic large cell lymphoma arising in the thrombus of an aortic prosthesis preceeded by clonally related lymphomatoid papulosis.
    Menter T; Ballova V; Caspar C; Wolff T; Kasenda B; Singer G; Juskevicius D; Tzankov A; Dirnhofer S
    Virchows Arch; 2019 Jun; 474(6):763-767. PubMed ID: 30685783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin's disease.
    Vermeer MH; Dukers DF; ten Berge RL; Bloemena E; Wu L; Vos W; de Vries E; Tensen CP; Meijer CJ; Willemze R
    Mod Pathol; 2002 Aug; 15(8):838-44. PubMed ID: 12181269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
    Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
    Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic use of mistletoe for CD30+ cutaneous lymphoproliferative disorder/lymphomatoid papulosis.
    Seifert G; Tautz C; Seeger K; Henze G; Laengler A
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):558-60. PubMed ID: 17374000
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
    Benner MF; Jansen PM; Meijer CJ; Willemze R
    Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.